Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/10/21 17:30 | 2/8/21 | KLDO | Health | BioPrd | Biological Products, (No Diag | Flagship Ventures Fund IV General Partner LLC | MA | T | P | 2,473 | 11.50 | 0 | 215 | 1 | 14,908 | I | |||||||||||||||
6/8/20 16:46 | 6/4/20 | KLDO | Health | BioPrd | Biological Products, (No Diag | Flagship Ventures Fund IV General Partner LLC | MA | T | P | 15,000 | 7.50 | 0 | 2,000 | 16 | 14,836 | I | |||||||||||||||
6/5/20 16:06 | 6/4/20 | KLDO | Health | BioPrd | Biological Products, (No Diag | Melas Kyriazi Theo | MA | D | P | 250 | 7.50 | 0 | 33 | New | 33 | D | |||||||||||||||
3/6/19 16:45 | 3/4/19 | KLDO | Health | BioPrd | Biological Products, (No Diag | Flagship Ventures Fund V General Partner LLC | MA | DT | P.d | 14,000 | 15.00 | 0 | 933 | 24 | 4,744 | I | |||||||||||||||
3/4/19 20:13 | 2/28/19 | KLDO | Health | BioPrd | Biological Products, (No Diag | Bonney Michael W | MA | DO | Exec Cha | P.d | 999 | 13.98 | 0 | 72 | 5 | 1,651 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |